Stefanie E Mayer1, Melissa Peckins2, Kate R Kuhlman3, Nirmala Rajaram4, Nestor L Lopez-Duran5, Elizabeth A Young4, James L Abelson4. 1. Department of Psychiatry, University of California, Street, Suite 465, San Francisco, CA, USA. Electronic address: Stefanie.Mayer@ucsf.edu. 2. Department of Psychology, St. John's University, NY, USA. 3. Department of Psychological Science, University of California, Irvine, CA, USA; Cousins Center for Psychoneuroimmunology, University of California Los Angeles, Los Angeles, CA, USA; Institute for Interdisciplinary Salivary Bioscience, University of California, Irvine, CA, USA. 4. Department of Psychiatry, University of Michigan, MI, USA. 5. Department of Psychology, University of Michigan, MI, USA.
Abstract
BACKGROUND: Much work has documented hypothalamic pituitary adrenal (HPA) axis abnormalities in major depressive disorder (MDD), but inconsistencies leave this system's role in the illness unclear. Comparisons across studies are complicated by variation in co-morbidity (Posttraumatic Stress Disorder-PTSD, anxiety disorders), exposure to trauma, and timing of trauma (child vs. adult). Here, we examined the impact of these factors on HPA axis profiles in depression. METHODS: We recruited 5 groups of participants: MDD (n = 14), comorbid MDD + PTSD following adulthood trauma (MDD + PTSD-Adult; n = 12), comorbid MDD + PTSD following childhood trauma (MDD + PTSD-Child; n = 18), comorbid MDD + social anxiety disorder (MDD + SAD; n = 12), and non-depressed control participants who were sex and age matched to patients (combined total n = 36). HPA axis function was assessed using three challenges: stress reactivity via the Trier Social Stress Test (TSST), feedback sensitivity via a dexamethasone suppression test (DST), and central drive via a metyrapone challenge (MET). We compared hormonal responses between patient groups and their respective non-depressed controls. RESULTS: MDD + PTSD-Child showed low cortisol levels at baseline, and reduced adrenocorticotropic hormone (ACTH) levels at baseline and throughout the TSST. MDD-only, MDD + PTSD-Adult, and MDD + SAD did not differ from non-depressed controls in HPA axis responses to the TSST. Controlling for childhood trauma severity, the reduced baseline levels in MDD + PTSD-Child were no longer significant and significantly reduced baseline cortisol levels emerged for MDD + PTSD-Adult. No diagnostic group effects were detected with DST and MET. Childhood maltreatment subtypes were associated with unique HPA axis responses to TSST and MET. CONCLUSION: Comorbidity and trauma exposure, as well as their timing and type, contribute to inconsistencies in the depression literature and must be included in efforts to clarify the role of the HPA axis in MDD.
BACKGROUND: Much work has documented hypothalamic pituitary adrenal (HPA) axis abnormalities in major depressive disorder (MDD), but inconsistencies leave this system's role in the illness unclear. Comparisons across studies are complicated by variation in co-morbidity (Posttraumatic Stress Disorder-PTSD, anxiety disorders), exposure to trauma, and timing of trauma (child vs. adult). Here, we examined the impact of these factors on HPA axis profiles in depression. METHODS: We recruited 5 groups of participants: MDD (n = 14), comorbid MDD + PTSD following adulthood trauma (MDD + PTSD-Adult; n = 12), comorbid MDD + PTSD following childhood trauma (MDD + PTSD-Child; n = 18), comorbid MDD + social anxiety disorder (MDD + SAD; n = 12), and non-depressed control participants who were sex and age matched to patients (combined total n = 36). HPA axis function was assessed using three challenges: stress reactivity via the Trier Social Stress Test (TSST), feedback sensitivity via a dexamethasone suppression test (DST), and central drive via a metyrapone challenge (MET). We compared hormonal responses between patient groups and their respective non-depressed controls. RESULTS:MDD + PTSD-Child showed low cortisol levels at baseline, and reduced adrenocorticotropic hormone (ACTH) levels at baseline and throughout the TSST. MDD-only, MDD + PTSD-Adult, and MDD + SAD did not differ from non-depressed controls in HPA axis responses to the TSST. Controlling for childhood trauma severity, the reduced baseline levels in MDD + PTSD-Child were no longer significant and significantly reduced baseline cortisol levels emerged for MDD + PTSD-Adult. No diagnostic group effects were detected with DST and MET. Childhood maltreatment subtypes were associated with unique HPA axis responses to TSST and MET. CONCLUSION: Comorbidity and trauma exposure, as well as their timing and type, contribute to inconsistencies in the depression literature and must be included in efforts to clarify the role of the HPA axis in MDD.
Authors: Ronald C Kessler; Katie A McLaughlin; Jennifer Greif Green; Michael J Gruber; Nancy A Sampson; Alan M Zaslavsky; Sergio Aguilar-Gaxiola; Ali Obaid Alhamzawi; Jordi Alonso; Matthias Angermeyer; Corina Benjet; Evelyn Bromet; Somnath Chatterji; Giovanni de Girolamo; Koen Demyttenaere; John Fayyad; Silvia Florescu; Gilad Gal; Oye Gureje; Josep Maria Haro; Chi-Yi Hu; Elie G Karam; Norito Kawakami; Sing Lee; Jean-Pierre Lépine; Johan Ormel; José Posada-Villa; Rajesh Sagar; Adley Tsang; T Bedirhan Ustün; Svetlozar Vassilev; Maria Carmen Viana; David R Williams Journal: Br J Psychiatry Date: 2010-11 Impact factor: 9.319
Authors: Audrey R Tyrka; Lawrence H Price; Joel Gelernter; Caroline Schepker; George M Anderson; Linda L Carpenter Journal: Biol Psychiatry Date: 2009-07-12 Impact factor: 13.382
Authors: Anthony P King; Maria Muzik; Lindsay Hamilton; Alexander B Taylor; Katherine L Rosenblum; Israel Liberzon Journal: PLoS One Date: 2016-08-05 Impact factor: 3.240
Authors: Kate Ryan Kuhlman; James L Abelson; Stefanie E Mayer; Nirmala Rajaram; Hedieh Briggs; Elizabeth Young Journal: Stress Date: 2021-06-01 Impact factor: 3.493